Grancell is conducting joint research with the Faculty of Medicine at the University of the Ryukyus, academic institutions, and companies.
Adipose Stem Cell Business Project
Adipose-derived stem cells (ASCs) are harvested and extracted at the University of the Ryukyus Hospital and other facilities, with quality and safety evaluations and storage systems established. This is a fundamental project to establish the first system in Japan to supply high-quality and safe stem cells in the future. In 2018, we had 30 stored samples. By 2025, we aim to achieve 500 stored samples, the largest number in Japan.
In this project, Grancell will jointly be in charge of safety and quality evaluation while the Faculty of Medicine at the University of the Ryukyus will be leading the research, with participation from academic institutions such as the National Center for Child Health and Development and the National Institute of Advanced Industrial Science and Technology, as well as CellSource Co., MTI Ltd., and TROPICAL TECHNOLOGY PLUS.
The establishment of the safety and quality control as well as the storage system for ASCs will contribute to regenerative medicine and drug development. This project is one of the important pillars of the “”OKINAWA BIO-INFORMATION BANK Plan”” set forth by Okinawa Prefecture and the Faculty of Medicine at the University of the Ryukyus.
ASCs Culture Method R&D
Grancell and the Faculty of Medicine at the University of the Ryukyus are conducting joint research on the development of ASCs culture methods. We are striving to establish a culture method that is more efficient and of higher quality.